DONADON, Matteo Davide
 Distribuzione geografica
Continente #
NA - Nord America 7.749
AS - Asia 3.484
EU - Europa 1.573
SA - Sud America 1.103
AF - Africa 257
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 14.180
Nazione #
US - Stati Uniti d'America 7.606
SG - Singapore 2.110
BR - Brasile 972
CN - Cina 693
FI - Finlandia 340
IE - Irlanda 256
IT - Italia 215
VN - Vietnam 193
NG - Nigeria 183
DE - Germania 171
FR - Francia 133
GB - Regno Unito 101
HK - Hong Kong 98
CA - Canada 86
NL - Olanda 82
SE - Svezia 69
TR - Turchia 67
AR - Argentina 54
AE - Emirati Arabi Uniti 50
IN - India 50
BE - Belgio 45
BD - Bangladesh 39
RU - Federazione Russa 39
MX - Messico 33
IQ - Iraq 30
ZA - Sudafrica 29
IL - Israele 25
PL - Polonia 22
EC - Ecuador 21
UA - Ucraina 20
ID - Indonesia 17
JP - Giappone 17
PK - Pakistan 17
UZ - Uzbekistan 17
ES - Italia 13
CL - Cile 12
MA - Marocco 12
BG - Bulgaria 11
CO - Colombia 10
PY - Paraguay 9
VE - Venezuela 8
CZ - Repubblica Ceca 7
IR - Iran 7
PE - Perù 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
KE - Kenya 6
LT - Lituania 6
RO - Romania 6
AL - Albania 5
AT - Austria 5
DZ - Algeria 5
GR - Grecia 5
KR - Corea 5
NP - Nepal 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EU - Europa 4
KG - Kirghizistan 4
OM - Oman 4
PA - Panama 4
PT - Portogallo 4
SA - Arabia Saudita 4
SN - Senegal 4
BO - Bolivia 3
EE - Estonia 3
EG - Egitto 3
JO - Giordania 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LU - Lussemburgo 3
PH - Filippine 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
ML - Mali 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BZ - Belize 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
Totale 14.169
Città #
Wilmington 1.290
Chandler 1.157
Singapore 695
The Dalles 524
San Mateo 498
Shanghai 401
Dallas 353
Ann Arbor 352
Helsinki 339
Dublin 253
Leawood 233
Lawrence 226
Princeton 226
Boardman 195
Ashburn 191
Benin City 183
Beijing 172
New York 169
Fairfield 131
Paris 118
Woodbridge 102
Hong Kong 97
São Paulo 83
Amsterdam 76
Ho Chi Minh City 71
Toronto 66
London 58
Milan 52
Los Angeles 48
Seattle 46
Kocaeli 45
Brussels 44
Phoenix 38
Hanoi 37
Rio de Janeiro 32
Norwalk 30
Columbus 29
San Diego 28
Belo Horizonte 24
Munich 24
Santa Clara 23
Council Bluffs 19
Warsaw 18
Johannesburg 17
Tashkent 17
Tokyo 17
Boston 16
Brooklyn 15
Monmouth Junction 15
Abbiategrasso 14
Brasília 14
Houston 14
Baghdad 13
San Francisco 13
Chennai 12
Falkenstein 12
Salvador 12
Cambridge 11
Chicago 11
Porto Alegre 11
Atlanta 10
Goiânia 10
Buenos Aires 9
Des Moines 9
Falls Church 9
Guarulhos 9
Moscow 9
Da Nang 8
Dhaka 8
Florence 8
Haiphong 8
Pune 8
Quito 8
Ribeirão Preto 8
Andover 7
Campinas 7
Curitiba 7
Guayaquil 7
Ipatinga 7
Lahore 7
Manaus 7
Osasco 7
Redwood City 7
Ankara 6
Aracaju 6
Belém 6
Cape Town 6
Denver 6
Erbil 6
Fortaleza 6
Frankfurt am Main 6
Lima 6
Maceió 6
Mexico City 6
Naples 6
Poplar 6
Praia Grande 6
Thái Nguyên 6
Araçatuba 5
Betim 5
Totale 9.314
Nome #
Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy 166
Back-flow bleeding control during resection of right-sided liver tumors by means of ultrasound-guided finger compression of the right hepatic vein at its caval confluence 120
Anatomical resection of segment 8 by means of ultrasound-guided vessel compression 114
Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy? 113
Safety of intermittent pringle maneuver cumulative time exceeding 120 minutes in liver resection : a further step in favor of the "radical but conservative" policy 97
AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS. 97
Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients 96
B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury 96
Hepatic resection for hepatocellular carcinoma in cirrhosis 95
Anatomical right posterior sectionectomy: a further expansion of the ultrasound-guided compression technique 89
Anatomical segmental and subsegmental resection of the liver for hepatocellular carcinoma: a new approach by means of ultrasound - guided vessel compression 89
A new systematic small for size resection for liver tumors invading the middle hepatic vein at its caval confluence: mini-mesohepatectomy 87
Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence 86
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers : is it adherent to the EASL/AASLD recommendations? : an observational study of the HCC east-west study group 85
Conservative Hepatectomy for Tumors Involving the Middle Hepatic Vein and Segment 1: The Liver Tunnel 84
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives 84
[Surgical treatment of liver metastases from colorectal carcinoma]. 82
"Radical but conservative" is the main goal for ultrasonography-guided liver resection : prospective validation of this approach 82
Approccio al paziente con ittero ostruttivo. 58esimo Capitolo 81
Right inferior phrenic vein indicating the right hepatic vein confluence into the inferior vena cava 80
Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis 80
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group Reply 80
Bevacizumab Improves Pathologic Response and Protects against Hepatic Injury in Patients Treated with Oxaliplatin-based Chemotherapy for Colorectal Liver Metastases 80
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 79
Hepatectomy for hepatocellular carcinoma in stage B and C of BCLC classification: A feasible, safe, and effective treatment 78
Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis : is it useful or useless? A prospective cohort study of our experience 78
Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases 77
The surgical margin in liver resection for hepatocellular carcinoma: a real problem or not 77
Inferior vena cava thrombosis : an unusual complication of a large simple non-parasitic liver cyst requiring an integrated approach 77
Utility of the hooking technique for cases of major hepatectomy 76
Total or partial anatomical resection of segment 8 using the ultrasound-guided finger compression technique 76
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 76
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 76
Safe Hepatectomy Selection Criteria for Hepatocellular Carcinoma Patients: A Validation of 336 Consecutive Hepatectomies. The BILCHE Score 75
Cholinesterases Predict Outcome in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma, Results From a Retrospective Analysis 74
Contrast-enhanced intraoperative ultrasonography : a valuable and not any more monocentric diagnostic technique performed in different ways 73
Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications 73
Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients : a multivariate analysis 73
The role of natural killer cells in autoimmune lIver disease : a comprehensive review 72
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 72
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 71
Technical tricks for radical but conservative liver resection. The ultrasound guidance 71
Ultrasound guided liver resection: does this approach limit the need for portal vein embolization? 71
Survivin gene expression in chronic liver disease and hepatocellular carcinoma 71
Does Inferior-Vena-Cava Collapsibility Correlate with Fluid Regimen and Outcome in Patients Undergoing Liver Resection? 71
Role of liver biopsy in hepatocellular carcinoma 71
Criteria for the selective use of contrast-enhanced intra-operative ultrasound during surgery for colorectal liver metastases 71
Upper transversal hepatectomy 70
Prospective Evaluation of Intrahepatic Microscopic Occult Tumor Foci in Patients with Numerous Colorectal Liver Metastases 70
Are Tumor Exposure and Anatomical Resection Antithetical during Surgery for Hepatocellular Carcinoma? A Critical Review 69
Ultrasound guided liver resection: Does this approach limit the need for portal vein embolization? 69
State of the Art of Intraoperative Ultrasound in Liver Surgery: Current Use for Staging and Resection Guidance 68
Systematic extended right posterior sectionectomy: a safe an effective alternative to righ hepatectomy 67
Filamin a expression predicts early recurrence of hepatocellular carcinoma 67
Hepatic Vein-Sparing Hepatectomy for Multiple Colorectal Liver Metastases at the Caval Confluence 67
Surgical strategy for liver tumors located at the hepato-caval confluence 67
Ultrasound guided liver resection: Does this approach limit the need for portal vein branches embolization? 67
Twelve-year experience of "radical but conservative" liver surgery for colorectal metastases: impact on surgical practice and oncologic efficacy 65
Defective DNAM-1 mediated cytotoxicity in NK cells infiltrating hepatocellular carcinoma 65
Macrophages in Colorectal Cancer Liver Metastases 65
Liver resection for primary hepatic neuroendocrine tumours : report of three cases and review of the literature 65
Care or palliation for recurrent hepatocarcinoma: a multicentric national analysis of survival 65
Immunotherapy in hepatobiliary tumors: search for the missing pieces of the puzzle 65
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 65
Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases 65
Radical but Conservative Liver Resection for Large Centrally Located Hepatocellular Carcinoma: The Mini Upper-Transversal Hepatectomy 64
Tailoring the area of hepatic resection using inflow and outflow modulation 64
Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival 64
Is Enhanced One-Stage Hepatectomy a Safe and Feasible Alternative to the Two-Stage Hepatectomy in the Setting of Multiple Bilobar Colorectal Liver Metastases? A Comparative Analysis between Two Pioneering Centers. 64
Diagnosis and Management of Bile Leaks After Hepatectomy: Results of a Prospective Analysis of 475 Hepatectomies 64
ONE STAGE HEPATECTOMY FOR MULTIPLE BILOBAR COLORECTAL LIVER METASTASES 64
Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study 64
Measurement of Total Liver Volume Using the Energy Expenditure: A New Formula 63
Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways 63
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 63
Assessment of the American College of Surgeons surgical risk calculator of outcomes after hepatectomy for liver tumors: Results from a cohort of 950 patients 63
Intraoperative ultrasound of the liver 62
Multiple focal nodular hyperplasias induced by oxaliplatin-based chemotherapy 62
Reply to "Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation" 62
Evaluation of Interaction Between NK Cells and Colorectal Carcinoma Cells for Development of NK Cell-Based Immunotherapy in Patients with Refractory Disease 62
Techniques for hepatectomies without blood transfusion, focusing on interpretation of postoperative anemia 62
Conservative but Radical Liver Surgery: the role of Intraoperative Ultrasonography 62
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 62
An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma 62
Monopolar floating ball versus bipolar forceps for hepatic resection: a prospective randomized clinical trial 61
Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort 61
The Liver Tunnel Intention-to-treat Validation of a New Type of Hepatectomy 61
Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients 61
Characterization of cholangiocarcinoma primary, circulating and metastatic stem-like cells 61
Effect of intratumoral CD3+and NKp46+cells on tumor progression in resected colorectal liver metastases treated with neoadjuvant chemotherapy. 61
Selection for resection of hepatocellular carcinoma and surgical strategy: Indications for resection, evaluation of liver function, portal vein embolization, and resection 61
Surgery for cholangiocarcinoma 61
Drop-out between the two liver resections of two-stage hepatectomy for multiple bilobar colorectal metastases: Patient selection or loss of chance? 60
R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management 60
Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis 60
CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study 60
Global characterization of tumor infiltrate of Intrahepatic Cholangiocarcinoma by single cell sequencing 60
Hepatocellular Carcinoma: The Role of Interventional Oncology 60
Hepatic vein management in a parenchyma-sparing policy for resecting colorectal liver metastases at the caval confluence 59
Parenchyma-Sparing Liver Surgery for Large Segment 1 Tumors: Ultrasound-Guided Lateral and Superior Approaches as Safe Alternatives to Major Hepatectomy 59
Totale 7.305
Categoria #
all - tutte 117.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.231 0 0 0 0 0 710 323 161 455 315 11 256
2021/20221.260 79 6 44 248 9 73 85 164 117 124 249 62
2022/20233.121 522 131 323 339 245 262 0 230 570 279 189 31
2023/20241.621 128 208 346 50 33 177 101 75 27 28 168 280
2024/20253.106 46 67 12 83 67 395 169 287 382 709 487 402
2025/20262.942 1.020 409 441 757 194 121 0 0 0 0 0 0
Totale 14.391